BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11371562)

  • 1. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues.
    Fantz DA; Jacobs D; Glossip D; Kornfeld K
    J Biol Chem; 2001 Jul; 276(29):27256-65. PubMed ID: 11371562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
    Burkhard KA; Chen F; Shapiro P
    J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.
    Jacobs D; Glossip D; Xing H; Muslin AJ; Kornfeld K
    Genes Dev; 1999 Jan; 13(2):163-75. PubMed ID: 9925641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.
    Bardwell AJ; Bardwell L
    J Biol Chem; 2015 Oct; 290(44):26661-74. PubMed ID: 26370088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1.
    Gavin AC; Nebreda AR
    Curr Biol; 1999 Mar; 9(5):281-4. PubMed ID: 10074458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation.
    Molina DM; Grewal S; Bardwell L
    J Biol Chem; 2005 Dec; 280(51):42051-60. PubMed ID: 16246839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3.
    Nichols A; Camps M; Gillieron C; Chabert C; Brunet A; Wilsbacher J; Cobb M; Pouyssegur J; Shaw JP; Arkinstall S
    J Biol Chem; 2000 Aug; 275(32):24613-21. PubMed ID: 10811804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of major ERK-related phosphorylation sites in Gab1.
    Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
    Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
    Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
    J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the Anti-proliferative protein Tob as a MAPK substrate.
    Maekawa M; Nishida E; Tanoue T
    J Biol Chem; 2002 Oct; 277(40):37783-7. PubMed ID: 12151396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.
    Bardwell AJ; Flatauer LJ; Matsukuma K; Thorner J; Bardwell L
    J Biol Chem; 2001 Mar; 276(13):10374-86. PubMed ID: 11134045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining docking interactions on ERK2 with modular peptide substrates.
    Lee S; Warthaka M; Yan C; Kaoud TS; Ren P; Dalby KN
    Biochemistry; 2011 Nov; 50(44):9500-10. PubMed ID: 21955038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling.
    Lin YW; Yang JL
    J Biol Chem; 2006 Jan; 281(2):915-26. PubMed ID: 16286470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN; Seternes OM; Gabrielsen M; Keyse SM
    J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site.
    Callaway K; Abramczyk O; Martin L; Dalby KN
    Biochemistry; 2007 Aug; 46(32):9187-98. PubMed ID: 17658892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of a MAPKā€¢substrate complex in an active conformation: a computational and experimental approach.
    Lee S; Warthaka M; Yan C; Kaoud TS; Piserchio A; Ghose R; Ren P; Dalby KN
    PLoS One; 2011 Apr; 6(4):e18594. PubMed ID: 21494553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.
    Ishihara K; Tsutsumi K; Kawane S; Nakajima M; Kasaoka T
    FEBS Lett; 2003 Aug; 550(1-3):107-13. PubMed ID: 12935895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.